Cancer Investigation
Volume 40, 2022 - Issue 7
Brief Report
Webinar as an Informational Resource on Trastuzumab Biosimilars: Planning, Promotion, Execution, and Evaluation
Elizabeth Lerner Papautskya Department of Biomedical & Health Information Sciences, University of Illinois at Chicago, Chicago, IL, USACorrespondence[email protected]
https://orcid.org/0000-0003-2771-9579View further author information
https://orcid.org/0000-0003-2771-9579View further author information, , , , , Deanna J. Attaid Department of Surgery, University of California Los Angeles, Los Angeles, CA, USAhttps://orcid.org/0000-0002-1893-1183View further author information
https://orcid.org/0000-0002-1893-1183View further author information, R. Donald Harveye Department of Hematology and Medical Oncology, Emory Winship Cancer Institute, Atlanta, GA, USAhttps://orcid.org/0000-0002-4217-1313View further author information
https://orcid.org/0000-0002-4217-1313View further author information, Gary H. Lymanf Public Health Sciences Division, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USAhttps://orcid.org/0000-0002-0823-8086View further author information
https://orcid.org/0000-0002-0823-8086View further author information & show all